Background
Methods
Patients
Data collection
Study definitions
-
Severe post-cardiac surgery patients defined as after conventional treatments, patients still have the following problems: a. lactate clearance less than 30% in the first 24 h;b. high dose of norepinephrine, more than 1μg/kg/min; c. undefined shock type, requiring more accurate monitoring techniques, like PiCCO.
-
PMV group: prolonged MV group, defined as MV > 6 days; non-PMV group: non-prolonged MV group, defined as MV ≤6 days.
-
End-systolic aortic pressure can be estimated as 0.9 times the peak brachial systolic pressure. In this study, we calculated Ea as 0.9*SBP divided by SV (stroke volume), which can be expressed as Ea = 0.9 SBP/SV.
-
The simplified formula for calculating Ees was Ees = SBP/(GEDV/4-SV). Technically, Ees = ESP/(ESV-V0). ESP is LV end-systolic pressure and ESV is LV end-systolic volume. V0 represents a purely theoretical LV volume at zero intracavitary pressure [16]. We considered ESP as 0.9*SBP [16] and left out V0. Global end-diastolic volume (GEDV) divided by 4 was used as the left ventricular end-diastolic volume.
Statistical analysis
Results
Demographics and clinical characteristics
Characteristics | Groups |
P
| |
---|---|---|---|
Non-prolonged MV (n = 30) | Prolonged MV (n = 26) | ||
Gender Males n (%) | 23 (76.67%) | 22 (84.62%) | 0.455 |
Age (years) | 49.90 ± 16.60 | 54.27 ± 16.52 | 0.329 |
SOFA | 11.09 ± 2.01 | 12.56 ± 2.71 | 0.003 |
MV (hours) | 97.33 ± 26.97 | 280.50 ± 141.65 | < 0.001 |
ICU LOS (days) | 8.13 ± 4.14 | 15.73 ± 7.02 | <0.001 |
Types of surgery | |||
CABG n (%) | 6 (20.00%) | 5 (19.23%) | 0.942 |
Pericardiectomy n (%) | 10 (33.33%) | 13 (50.00%) | 0.206 |
Valve surgery n (%) | 13 (43.33%) | 9 (34.62%) | 0.505 |
Ventricular septal defect repair n (%) | 0 (00.00%) | 1 (3.85%) | 0.464 |
Atrial neoplasms resection n (%) | 2 (6.67%) | 0 (0.00%) | 0.282 |
Replacement of aorta n (%) | 1 (3.33%) | 0 (0.00%) | 1.000 |
ECC duration (min) | 116.21 ± 98.56 | 82.56 ± 79.50 | 0.200 |
Concomitant diseases | |||
Hypertension n (%) | 11 (36.67%) | 6 (23.08%) | 0.270 |
Diabetes n (%) | 7 (23.33%) | 3 (11.54%) | 0.310 |
CAC n (%) | 8 (26.67%) | 5 (19.23%) | 0.511 |
CKD n (%) | 4 (13.33%) | 1 (3.85%) | 0.358 |
CHF n (%) | 8 (26.67%) | 9 (34.62%) | 0.519 |
Post-surgery drugs | |||
Vasopressors | |||
0-24 h n (%) | 28 (93.33%) | 26 (100%) | 0.494 |
24-48 h n (%) | 25 (83.33%) | 26 (100%) | 0.055 |
> 48 h n (%) | 24 (80.00%) | 26 (100%) | < 0.001 |
Intropes | |||
0-24 h n (%) | 28 (93.33%) | 25 (96.15%) | 1.000 |
24-48 h n (%) | 28 (93.33%) | 25 (96.15%) | 1.000 |
> 48 h n (%) | 19 (63.33%) | 20 (76.92%) | 0.384 |
Relationship between hemodynamic parameters and the duration of MV
Variables | Times | Non-prolonged MV | n | Prolonged MV | n |
P
|
---|---|---|---|---|---|---|
HR bpm | T0 | 103 ± 15 | 30 | 110 ± 17 | 26 | 0.113 |
T1 | 97 ± 13 | 30 | 108 ± 13 | 26 | 0.018 | |
SBP mmHg | T0 | 129 ± 17 | 30 | 129 ± 15 | 26 | 0.938 |
T1 | 131 ± 17 | 30 | 118 ± 22 | 26 | 0.014 | |
CVP mmHg | T0 | 10.03 ± 2.80 | 30 | 11.08 ± 3.72 | 26 | 0.237 |
T1 | 10.59 ± 2.15 | 29 | 9.35 ± 2.55 | 26 | 0.055 | |
P/F mmHg | T0 | 355.00 ± 172.43 | 30 | 291.65 ± 91.29 | 23 | 0.092 |
T1 | 293.90 ± 93.65 | 29 | 280.48 ± 120.81 | 25 | 0.648 | |
T °C | T0 | 36.03 ± 0.79 | 30 | 35.87 ± 0.66 | 26 | 0.406 |
T1 | 36.78 ± 0.61 | 30 | 36.63 ± 0.72 | 26 | 0.319 | |
Lac mmol/L | T0 | 5.56 ± 3.80 | 30 | 5.66 ± 3.99 | 23 | 0.928 |
T1 | 1.46 ± 0.58 | 29 | 2.42 ± 1.24 | 25 | < 0.001 | |
CI L/min/m2 | T0 | 2.89 ± 0.81 | 18 | 2.90 ± 0.87 | 17 | 0.988 |
T1 | 2.82 ± 0.63 | 21 | 2.59 ± 0.80 | 21 | 0.318 | |
SVI ml/m2 | T0 | 27.12 ± 7.75 | 18 | 26.24 ± 8.04 | 17 | 0.887 |
T1 | 29.52 ± 10.84 | 21 | 23.58 ± 6.75 | 21 | 0.049 | |
SVRI dyn.sec.cm−5.m2 | T0 | 2399.06 ± 1146.16 | 17 | 2255.71 ± 883.40 | 17 | 0.615 |
T1 | 2260.71 ± 668.84 | 24 | 2309.76 ± 555.38 | 23 | 0.980 | |
Ea mmHg/ml | T0 | 2.62 ± 1.07 | 18 | 2.86 ± 1.38 | 17 | 0.566 |
T1 | 2.57 ± 1.22 | 21 | 2.93 ± 0.91 | 21 | 0.279 | |
Ees mmHg/ml | T0 | 0.570 ± 0.175 | 18 | 0.523 ± 0.109 | 17 | 0.346 |
T1 | 0.578 ± 0.179 | 21 | 0.461 ± 0.136 | 21 | 0.022 | |
Ea/Ees | T0 | 4.39 ± 1.90 | 18 | 4.89 ± 1.80 | 17 | 0.423 |
T1 | 4.05 ± 1.20 | 21 | 5.93 ± 1.81 | 21 | < 0.001 |
Multivariable binary logistic regression
Variable | B | SE | Wald | P | OR | 95% CI for OR Lower Upper | |
---|---|---|---|---|---|---|---|
Multivariate | |||||||
Age years | 0.040 | 0.050 | 0.625 | 0.429 | 1.040 | 0.943 | 1.148 |
SOFA | 0.012 | 0.361 | 0.001 | 0.974 | 1.012 | 0.498 | 2.055 |
T1 SBP mmHg | −0.083 | 0.039 | 4.495 | 0.034 | 0.921 | 0.853 | 0.994 |
T1 HR bpm | 0.103 | 0.085 | 1.459 | 0.227 | 1.108 | 0.938 | 1.310 |
T1 CVP mmHg | −0.300 | 0.278 | 1.164 | 0.281 | 0.741 | 0.430 | 1.277 |
T1 CI L/min/m2 | −1.771 | 1.788 | 0.982 | 0.322 | 0.170 | 0.005 | 5.657 |
T1 SVI ml/m2 | 0.196 | 0.183 | 1.150 | 0.284 | 1.216 | 0.850 | 1.739 |
T1 Ea/Ees | 1.923 | 0.966 | 3.965 | 0.046 | 6.840 | 1.031 | 45.395 |
T1 Lac mmol/L | 2.726 | 1.285 | 4.501 | 0.034 | 15.269 | 1.231 | 189.427 |
Predictive value of three variables in prolonged mechanical ventilation
Variables | ROC area | 95%CI | Cutoff value | Sensitivity | Specificity |
---|---|---|---|---|---|
Lac (mmol/L) | 0.816* | 0.680–0.952 | 1.60 | 75% | 85% |
Ea/Ees | 0.801* | 0.664–0.938 | 5.12 | 65% | 90% |
SOFA | 0.766* | 0.616–0.916 | 12.5 | 70% | 80% |